The findings from this study revealed that M2 and M0 macrophages were highly expressed in high-risk patients with breast cancer, whereas CD8+ T cells and naive B cells were highly expressed in low-risk patients with breast cancer. The gene discussed is CD8A; the disease is breast cancer.